跳转到主要内容
主页 / 资源 / 网络研讨会点播 / Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations

Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations

2021 年 6 月 17 日
网络研讨会点播
YouTube video

This fourth webinar in the “Let’s Talk MPTs” learning series will provide MPT product developers and other stakeholders an overview of clinical development and regulatory considerations when developing products that combine one or more active pharmaceutical ingredients (APIs) into an MPT product.

演讲嘉宾

• Deven Shah – Chemistry, Manufacturing, & Control (CM&C) Lead at Certara
• Kevin Hershberger – Vice President of Integrated Drug Development at Certara
• Tamra Goodrow – Regulatory Consultant & Principal at Deer Run Regulatory Consulting

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software